P. Cook

发表

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.

S. Fosså, D. Dearnaley, A. Horwich, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CLINICAL STUDIES

M. Williams, S. Fosså, P. Gerszten, 2004 .

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

M. Williams, S. Fosså, A. Horwich, 1999, British Journal of Cancer.

Postchemotherapy residual masses in germ cell tumor patients

S. Fosså, A. Horwich, C. Fisher, 1998, Cancer.

Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group.

S. Fosså, A. Horwich, G. Mead, 1998, The Journal of urology.

Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20).

L. Collette, S. Fosså, N. Aaronson, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postchemotherapy Residual Masses in Germ Cell Tumor Patients. Content, Clinical Features, and Prognosis

S. Fosså, A. Horwich, C. Fisher, 1999 .

Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party.

A. Horwich, G. Rustin, S. Kaye, 1997, European journal of cancer.

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

R. Huddart, G. Rustin, G. Mead, 2005, British Journal of Cancer.

The familial influence on bilateral testicular germ cell cancer: Medical Research Council study TER2.

A. Horwich, G. Mead, G. Daugaard, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

D. Dearnaley, A. Horwich, R. Sylvester, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy.

S. Fosså, A. Horwich, S. Kaye, 1997, European journal of cancer.

Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. An interim report.

S. Fosså, A. Horwich, S. Stenning, 1993, European urology.

GONADOTROPIN AND SEX-HORMONE LEVELS IN TESTIS CANCER-PATIENTS WITH AND WITHOUT CARCINOMA IN-SITU OF THE CONTRALATERAL TESTIS

S. Fosså, A. Horwich, S. Stenning, 1994 .

A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix.

J. Horiot, D. Machin, S. Dische, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)

M. Williams, S. Fosså, D. Dearnaley, 2005, British Journal of Cancer.

Final analysis demonstrating the equivalence of 3 BEP vs 4 cycles and the 5 day schedule vs 3 days per cycle in good prognosis germ cell cancer. An EORTC / MRC Phase III Study

L. Collette, P. Wilkinson, G. Mead, 2000 .

International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

Richard Sylvester, Andrew Kramar, Madhu Mazumdar, 1997 .

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.

A. Horwich, P. Wilkinson, E. Newlands, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.

A. Horwich, S. Kaye, S. Stenning, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial

P. Fayers, S. Fosså, M. Parmar, 1999 .

On the development of the Medical Research Council trial of alpha-interferon in metastatic renal carcinoma. Urological Working Party Renal Carcinoma Subgroup.

John Whitehead, Peter Fayers, David Machin, 1994, Statistics in medicine.

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high risk clinical stage I (HRCS 1) non-seminomatous germ cell tumours (NSGCT) - a Medical Research Council (MRC) pilot study.

M. Williams, S. Fosså, D. Dearnaley, 1998 .

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

R. Huddart, G. Rustin, G. Mead, 2005, British Journal of Cancer.

Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

A. Cuschieri, J. Bancewicz, J. Craven, 1996, Lancet.